Mereo BioPharma Group (MREO)
NASDAQ: MREO
· Real-Time Price · USD
1.74
0.03 (1.75%)
At close: Aug 15, 2025, 3:59 PM
1.74
0.00%
After-hours: Aug 15, 2025, 07:50 PM EDT
Mereo BioPharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -47.19M | -43.25M | -43.91M | -36.91M | -38.26M | -41.39M | -51.34M | -53.77M | -65M | -65.51M | -46.98M | -36.12M | 5.5M | 26.42M | -25.39M | -50.98M | -224.7M |
Depreciation & Amortization | 573.33K | 704.17K | 793.8K | 1.26M | 1.5M | 1.45M | 1.46M | 1.29M | 1.33M | 1.39M | 1.55M | 1.61M | 1.43M | 1.32M | 1.56M | 1.67M | 2.59M |
Stock-Based Compensation | 7.62M | 7.39M | 7.11M | 6.65M | 5.37M | 4.95M | 4.63M | 4.37M | 5.06M | 5.03M | 5.16M | 5.18M | 4.91M | 4.51M | 3.91M | 3.29M | 2.64M |
Other Working Capital | 1.16M | n/a | 768.73K | -306.34K | -2.53M | -1.81M | -2.1M | -3.41M | -603.25K | -162.25K | 151.09K | 1.64M | -1.71M | -1.71M | -2.02M | -2.02M | -4.64M |
Other Non-Cash Items | 1.57M | 4.66M | 10.32M | 4.99M | 16.44M | 13.28M | 9.71M | 5.99M | -7.45M | -9.26M | -30.49M | -40.09M | -35.13M | -35M | 13.53M | 39.03M | 184.54M |
Deferred Income Tax | n/a | n/a | 8.77M | 8.77M | n/a | n/a | -9.86M | -9.86M | -2.97M | -2.97M | -1.88M | -1.88M | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 2.13M | 622.17K | 3.11M | 6.47M | -2.8M | -925.75K | -4.34M | -9.21M | 840.47K | 686.87K | 2.14M | 4.54M | -1.56M | -2.94M | -3.89M | -4.18M | -5.16M |
Operating Cash Flow | -33.17M | -32.83M | -25.53M | -20.48M | -29.31M | -30.57M | -49.07M | -60.52M | -67.95M | -71.05M | -71.33M | -67.6M | -29.69M | -10.51M | -15.63M | -16.51M | -45M |
Capital Expenditures | 679.22K | -382 | 415.2K | -284.02K | -699.6K | -419K | -833.36K | -834.29K | -431.67K | -19.24K | -749.46K | -1.11M | -1.1M | -1.09M | -381.35K | -31.21K | -31.21K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 355.03K | 355.03K | -462.23K |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -998K | -1.4M | -1.69M | -1.28M | -1.2M | -418.38K | -224.34K | 516.86K | 1.48M | 2.05M | 2.3M | 1.93M | 877.1K | 231.49K | -19.18K | -223.06K | 2.25M |
Investing Cash Flow | -319.4K | -699K | -991.31K | -1.28M | -1.7M | -1.42M | -1.22M | -481.41K | 972.45K | 2.03M | 1.55M | 818.65K | -218.94K | -857.97K | -491.29K | -345.02K | 1.76M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 46.57M | 46.15M | 50.76M | 55.9M | 9.18M | 8.62M | 4.32M | 40.58K | -204.14K | 169.09K | -347.53K | -850.08K | 107.66M | 161.62M | 147.87M | 138.55M | 93.35M |
Financial Cash Flow | 46.57M | 46.15M | 50.76M | 55.9M | 8.94M | 8.37M | 3.26M | -1.02M | -1.22M | -849.74K | -2.83M | -3.33M | 105.38M | 159.34M | 147.87M | 138.55M | 93.35M |
Net Cash Flow | 12.91M | 12.38M | 26.78M | 36.98M | -16.01M | -15.62M | -44.34M | -81.83M | -102.52M | -105.89M | -105.23M | -81.67M | 73.25M | 144.7M | 130.94M | 120.07M | 48.61M |
Free Cash Flow | -33.19M | -33.53M | -25.81M | -20.77M | -30.01M | -30.99M | -49.9M | -61.36M | -68.38M | -71.07M | -72.08M | -68.71M | -30.79M | -11.6M | -16.01M | -16.54M | -45.03M |